UBS Group’s Corazon Capital V838 Monoceros Corp Unit CRZNU Stock Holding History

UBS Group’s Portfolio CRZNU Stock Details CRZNU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,632	Closed	-$36.6K	–	11262
2022 Q4	$36.6K	Buy	3,632 +2,541	+233%	+$25.3K	﹤0.01%	7044
2022 Q3	$11K	Sell	1,091 -210	-16%	-$2.07K	﹤0.01%	8370
2022 Q2	$13K	Sell	1,301 -114	-8%	-$1.12K	﹤0.01%	7605
2022 Q1	$14K	Sell	1,415 -200	-12%	-$1.97K	﹤0.01%	7997
2021 Q4	$16K	Buy	1,615 +1,000	+163%	+$9.96K	﹤0.01%	8205
2021 Q3	$6K	Buy	+615	New	+$6.15K	﹤0.01%	8480
2021 Q2	–	Sell	-5,554	Closed	-$55K	–	10059
2021 Q1	$55K	Buy	+5,554	New	+$55K	﹤0.01%	6456

UBS Group's CRZNU Position: Q1 2023 in Review

UBS Group sold out of Corazon Capital V838 Monoceros Corp Unit (CRZNU) in Q1 2023, closing a stake of 3,632 shares — an estimated $36.6K sold.

UBS Group first reported a position in CRZNU in Q1 2021 and held it in 7 quarters. The position peaked at $55K in Q1 2021. 0 funds tracked by Wall St. Rank hold CRZNU as of Q1 2023.

UBS Group reported no remaining Corazon Capital V838 Monoceros Corp Unit position as of Q1 2023 after selling out during the quarter.
UBS Group sold 3,632 Corazon Capital V838 Monoceros Corp Unit shares in Q1 2023, an estimated $36.6K.
UBS Group first reported a position in Corazon Capital V838 Monoceros Corp Unit in Q1 2021 and held it in 7 quarters.
UBS Group's Corazon Capital V838 Monoceros Corp Unit position peaked at $55K in Q1 2021.
0 funds tracked by Wall St. Rank held Corazon Capital V838 Monoceros Corp Unit as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.